Targeted Disruption of the β3-Adrenergic Receptor Gene
Vedrana S. Susulic(Janssen (Belgium)), Bradford B. Lowell(Beth Israel Deaconess Medical Center), Barbara B. Kahn(Beth Israel Deaconess Medical Center), Mary‐Ellen Harper(University of Ottawa), Effie Tozzo(Harvard University), Jean Himms‐Hagen(University of Ottawa), Robert Frederich(Pfizer (United States)), Jeffrey S. Flier(Harvard University), Joel Lawitts(Harvard University)
Cited by 496
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
TLR4 links innate immunity and fatty acid–induced insulin resistance
|Journal of Clinical Investigation|2006|3.6k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k